Literature DB >> 19590427

Role of the gastric refluxate in gastroesophageal reflux disease: acid, weak acid and bile.

Joel E Richter1.   

Abstract

The role of acid, weak/nonacid, and bile in the genesis of esophageal mucosal damage and reflux symptoms is complex. Acid combined with pepsin and unconjugated bile acids are critical to the development of esophagitis and Barrett's esophagus. Acid alone may be the principal factor in determining the severity of esophagitis. Weak acid or nonacid reflux does not cause esophageal damage or damage to adjacent organs, such as the larynx or lungs. The primary cause of heartburn and regurgitation is acid reflux, but a minority of symptoms (5%-15%) can be triggered by weak acid or bile reflux. The role is changed among patients on proton pump inhibitors with persistent symptoms, where the majority of symptoms are now due to weak acid or bile reflux. The proximal extent of the reflux, regardless of its acidity, seems to be the key to reflux symptoms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19590427     DOI: 10.1097/MAJ.0b013e3181ad584a

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  12 in total

Review 1.  Is alcohol consumption associated with gastroesophageal reflux disease?

Authors:  Shao-hua Chen; Jie-wei Wang; You-ming Li
Journal:  J Zhejiang Univ Sci B       Date:  2010-06       Impact factor: 3.066

2.  Gastroesophageal Reflux-Is It Uncommon in Indian Patients With Decompensated Liver Cirrhosis?

Authors:  Uday Sanglodkar; Mayank Jain; M J Alexander; Jayanthi Venkataraman
Journal:  J Clin Exp Hepatol       Date:  2018-10-05

3.  Gastroesophageal reflux in cirrhotic patients without esophageal varices.

Authors:  Jun Zhang; Pei-Lin Cui; Dong Lv; Shi-Wei Yao; You-Qing Xu; Zhao-Xu Yang
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

4.  Does impaired gallbladder function contribute to the development of Barrett's esophagus and esophageal adenocarcinoma?

Authors:  Ayman O Nassr; Syeda Nadia Shah Gilani; Mohammed Atie; Tariq Abdelhafiz; Val Connolly; Neil Hickey; Thomas Noel Walsh
Journal:  J Gastrointest Surg       Date:  2011-04-12       Impact factor: 3.452

5.  Serotonin disrupts esophageal mucosal integrity: an investigation using a stratified squamous epithelial model.

Authors:  Liping Wu; Tadayuki Oshima; Toshihiko Tomita; Yoshio Ohda; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2016-03-16       Impact factor: 7.527

6.  Non-erosive reflux disease (NERD), symptomatic and asymptomatic erosive reflux disease (ERD): from hypersensitive to hyposensitive esophagus.

Authors:  Juanda L Hartono; Choon-Seng Qua; Khean-Lee Goh
Journal:  Dig Dis Sci       Date:  2010-05-14       Impact factor: 3.199

7.  Influence of percutaneous local therapy for hepatocellular carcinoma on gastric function.

Authors:  Mitsuyoshi Kobayashi; Fumihiko Kinekawa; Kazuya Matsuda; Shintaro Fujihara; Noriko Nishiyama; Takako Nomura; Joji Tani; Hisaaki Miyoshi; Hideki Kobara; Akihiro Deguchi; Hirohito Yoneyama; Hirohito Mori; Tsutomu Masaki
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

8.  High prevalence of reflux esophagitis among upper endoscopies in Chinese patients with chronic liver diseases.

Authors:  Bing Li; Bin Zhang; Jun Wei Ma; Peng Li; Lei Li; Yun Ming Song; Hui Guo Ding
Journal:  BMC Gastroenterol       Date:  2010-06-04       Impact factor: 3.067

9.  Esophageal intraluminal baseline impedance is associated with severity of acid reflux and epithelial structural abnormalities in patients with gastroesophageal reflux disease.

Authors:  Chanjuan Zhong; Liping Duan; Kun Wang; Zhijie Xu; Ying Ge; Changqing Yang; Yajing Han
Journal:  J Gastroenterol       Date:  2012-10-18       Impact factor: 7.527

10.  Pepsin and bile acid concentrations in sputum of mustard gas exposed patients.

Authors:  Ashraf Karbasi; Hassan Goosheh; Rasoul Aliannejad; Hamid Saber; Maryam Salehi; Mahvash Jafari; Saber Imani; Amin Saburi; Mostafa Ghanei
Journal:  Saudi J Gastroenterol       Date:  2013 May-Jun       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.